| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |